NCT02823184View on ClinicalTrials.gov

Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms

CompletedOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

April 27, 2019

Study Completion Date

April 27, 2019

Conditions
Polycythemia VeraEssential Thrombocythemia
Interventions
BIOLOGICAL

RNA sample of total leukocytes before start of treatment

RNA sample of total leukocytes before start of treatment

Trial Locations (7)

Unknown

Chu Angers, Angers

Ch de La Cöte Basque, Bayonne

Chu de Bordeaux, Bordeaux

Crlcc Bergonie, Bordeaux

Chu de Brest, Brest

Ch de Dax, Dax

Ch de Libourne, Libourne

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02823184 - Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms | Biotech Hunter | Biotech Hunter